FDA News

FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug: Implications for SCD Pipeline and BD Strategy

FDA · sickle cell disease · 4 min

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

FDA · lung cancer · 6 min

FDA Shakeup: Høeg's Departure and Amgen Drug Controversy

FDA · 5 min

Bio-IT World Conference 2026: Live Event Coverage

FDA · 5 min

FDA Flashback: Key Breast Cancer Decisions from April 2026

FDA · breast cancer · 7 min

Fierce Biotech Week 2026: Key Insights and Highlights

FDA · 6 min

ASCO Preview: Akeso's Ivonescimab Under Scrutiny

FDA · oncology · 6 min

AstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma

FDA · breast cancer · 5 min

BioMarin Rare Disease Therapy Fails Phase 3: Key Takeaways for Pharma Teams

FDA · rare disease · 6 min

Kenya Court Halts U.S. Ebola Quarantine Facility Plans: Pharma Sector Analysis

FDA · Ebola · 6 min

Pharma in Focus: Regulatory Updates You Need to Know

FDA · 5 min

Kailera's Triple-G Drug: A Potential Game-Changer in Pharma

FDA · 5 min